Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Central South University(Medical Sciences) ; (12): 1012-1018, 2008.
Article in Chinese | WPRIM | ID: wpr-814159

ABSTRACT

OBJECTIVE@#To determine the effect of activation of specific anti-tumor cytotoxic T lymphocytes (CTL) and the ability of cross-presentation in vitro by fusion of HLA-A2+ human dendritic cells (DCs) with HLA-A2- melanoma cells.@*METHODS@#The HLA-A2+ human dendritic cells and HLA-A2- melanoma cells were fused by PEG and were cultivated in complete RPMI1640 media containing FCS (10%) and GM-CSF for 24-48 h, and then co-cultured fusion cells with Melan-A specific T cells. HLA-A2- melanoma cells were negative control,While T2 cells and DC+Pts were positive control. The activation of anti-tumor CTL elicited by the fusion cells was detected by intracellular cytokine staining.@*RESULTS@#The immature DC could express CD80, CD83, CD86, HLA-DR, and HLA-ABC,but the mature DC induced by TNF-alpha, PGE-2, and CD40L further highly expressed above molecules. The rate of specific CTL cells primed by the fusion cells was 16.72%+/-4.26%, negative control was 0.21%+/-1.84%,and positive control was 28.60%+/-5.67%. The CTL from vaccine by fusing DC and LAR6 induced lysis of HLA-A2+ LAR1 cells.@*CONCLUSION@#The HLA-A2 restricted specific anti-tumor CTL can be induced in vitro by fusion of HLA-A2+ human dendritic cells with HLA-A2- melanoma cells.


Subject(s)
Humans , Antigen Presentation , Allergy and Immunology , Antigens, Neoplasm , Allergy and Immunology , Cancer Vaccines , Allergy and Immunology , Cell Fusion , Cell Line, Tumor , Dendritic Cells , Cell Biology , Allergy and Immunology , HLA-A2 Antigen , Allergy and Immunology , MART-1 Antigen , Allergy and Immunology , Melanoma , Allergy and Immunology , Pathology , T-Lymphocytes, Cytotoxic , Allergy and Immunology
2.
Journal of Central South University(Medical Sciences) ; (12): 283-287, 2005.
Article in Chinese | WPRIM | ID: wpr-813381

ABSTRACT

OBJECTIVE@#To observe the biological behavior of canine bone marrow stromal cells (BMSCs) cultured in vitro with the astragalus polysaccharides-chitosan/polylactic acid (AP-C/PLA) and with the chitosan/polylactic acid (C/PLA) and to find a suitable compound material for periodontal tissue engineering.@*METHODS@#BMSCs (induced 14 days by 50 mg/L vitamine C, 10(-8) mol/L dexamethasone, 10 mmol/L beta-sodium glycerylphosphate) were cultured on AP-C/PLA or C/PLA for 5 days respectively. The BMSCs attachment and the morphology were observed with scanning electronic microscope and the combining rates were counted. Type I collagen synthesis was examined with immunohistochemistry staining and the content of osteocalin was determined with radio-immunological method.@*RESULTS@#Combining rates, type I collagen synthesis, and the content of osteocalin of BMSCs on AP-C/PLA were significantly higher than those on C/PLA.@*CONCLUSION@#AP-C/PLA may promote the BMSC proliferation, differentiation and extracellular matrix synthesis, and it can be used as a good scaffold material for bone tissue engineering.


Subject(s)
Animals , Dogs , Female , Male , Astragalus propinquus , Bone Marrow Cells , Cell Biology , Cell Proliferation , Cells, Cultured , Chitosan , Pharmacology , Collagen Type I , Drugs, Chinese Herbal , Pharmacology , Extracellular Matrix , Metabolism , Lactic Acid , Pharmacology , Osteocalcin , Polyesters , Polymers , Pharmacology , Polysaccharides , Pharmacology , Stromal Cells , Cell Biology , Tissue Engineering
SELECTION OF CITATIONS
SEARCH DETAIL